Shares of CVS Health Corp. CVS inched 0.11% higher to $45.82 Monday, on what proved to be an all-around mixed trading session ...

Analysts have recently evaluated CVS Health and provided 12-month price targets. The average target is $68.07, accompanied by ...

CVS Health's Medicaid business is experiencing medical cost pressure from higher-than-expected acuity following the ...

CVS' Aetna sues drug manufacturers for price-fixing and market allocation scheme. The subsidiary seeks damages and ...

CVS Health has been named as a Top 25 dividend stock, according the most recent Dividend Channel "DividendRank" report.

All of the commercial prescriptions dispensed at CVS pharmacies will be processed through its CostVantage reimbursement model ...

We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at ...

Billionaire entrepreneur Mark Cuban has been vocal about reshaping the U.S. health care system for years. During recent ...

Below is a roundup of payer-centric news headlines you may have missed during the month of December 2024 and over the ...

CVS Caremark will add Zydus' ZituvioTM and combination products to its template formulary starting January 1, 2025 ...

CVS Health has announced that starting this year, all commercial prescriptions dispensed through CVS Pharmacy will be contracted through its new CVS CostVantage reimbursement model.

Zituvimet (sitagliptin and metformin hydrochloride) and Zituvimet XR (sitagliptin and metformin hydrochloride) extended-release tablets.